Avzivi 25 mg / mL concentrate for solution for infusion

Licence status
Authorised: 26/07/2024
Active substances
Bevacizumab Biosimilar
Dosage Form
Concentrate for solution for infusion
Licence number
EU/1/24/1834/001-002
Licence holder
FGK Representative Service GmbH

Product documents

Licence information

ATC code
L01FG01 bevacizumab
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
26/07/2024